Penumbra Net Profit Margin 2014-2022 | PEN

Penumbra net profit margin from 2014 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
Penumbra Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $0.78B $-0.01B -0.90%
2021-12-31 $0.75B $0.00B 0.67%
2021-09-30 $0.71B $0.03B 4.79%
2021-06-30 $0.67B $0.02B 2.38%
2021-03-31 $0.59B $-0.00B -0.84%
2020-12-31 $0.56B $-0.02B -2.86%
2020-09-30 $0.54B $-0.01B -1.86%
2020-06-30 $0.53B $0.01B 1.90%
2020-03-31 $0.56B $0.04B 7.01%
2019-12-31 $0.55B $0.05B 8.96%
2019-09-30 $0.52B $0.05B 8.80%
2019-06-30 $0.50B $0.02B 3.23%
2019-03-31 $0.47B $0.01B 2.55%
2018-12-31 $0.45B $0.01B 1.35%
2018-09-30 $0.42B $0.01B 1.90%
2018-06-30 $0.39B $0.03B 6.87%
2018-03-31 $0.36B $0.01B 3.30%
2017-12-31 $0.33B $0.00B 1.20%
2017-09-30 $0.31B $-0.01B -2.25%
2017-06-30 $0.29B $0.01B 1.70%
2017-03-31 $0.28B $0.01B 3.60%
2016-12-31 $0.26B $0.02B 5.70%
2016-09-30 $0.24B $0.02B 7.38%
2016-06-30 $0.23B $0.01B 2.64%
2016-03-31 $0.20B $0.00B 0.98%
2015-12-31 $0.19B $0.00B 0.54%
2015-06-30 $0.11B $-0.00B -0.88%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $4.736B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.627B 21.80
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
STERIS (STE) Ireland $21.113B 26.67
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Integer Holdings (ITGR) United States $2.383B 18.51
Glaukos (GKOS) United States $2.256B 0.00
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Paragon 28 (FNA) United States $1.281B 0.00
Artivion (AORT) United States $0.772B 83.52